FDG-PET/CT与静息心肌灌注显像预测心脏结节病高度房室传导阻滞恢复
本研究为单中心回顾性分析,纳入27例表现为高度房室传导阻滞的心脏结节病患者,采用FDG-PET/CT联合静息心肌灌注显像进行疾病分期,评估其预测房室传导阻滞恢复的能力。结果显示,分期1期患者恢复率78.6%,恢复组中1期占比显著高于未恢复组(84.6% vs 21.4%,P=.002);2期患者仅18.2%恢复,未恢复组中2期占比更高(64.3% vs 15.4%,P=.020)。作者认为联合影像分期对预测恢复可能性似乎有良好表现。
要点
- 分期1期患者恢复率78.6%(11/14),恢复组中1期占比显著高于未恢复组(84.6% vs 21.4%,P=.002)。
- 分期2期患者仅18.2%(2/11)恢复,未恢复组中2期占比显著更高(64.3% vs 15.4%,P=.020)。
核心结论
- 联合FDG-PET与静息心肌灌注显像对心脏结节病合并高度房室传导阻滞进行分期,似乎能较好地预测房室传导恢复的可能性。
- 恢复组中分期1期占比显著高于未恢复组(84.6% vs 21.4%,P=.002),未恢复组中分期2期占比显著更高(64.3% vs 15.4%,P=.020)。
研究设计与样本
- 单中心回顾性分析,纳入表现为高度房室传导阻滞并接受FDG-PET/CT联合静息心肌灌注显像的心脏结节病患者。
- 心脏结节病诊断采用2016年JCS标准和2014年HRS标准。
- 排除有冠心病史或既往接受免疫抑制治疗的患者,将患者分为房室传导阻滞恢复组与未恢复组。
主要发现
- 共识别27例患者,其中13例房室传导阻滞恢复。
- 分期1期患者14例中11例(78.6%)恢复房室传导。
- 分期2期患者11例中仅2例(18.2%)恢复房室传导。
关键数值与推荐
- 疾病分期基于FDG-PET与静息心肌灌注显像:0期为FDG-PET和静息心肌灌注显像均正常。
- 1期为FDG-PET阳性而静息心肌灌注显像正常。
- 2期为FDG-PET阳性且静息心肌灌注显像存在灌注缺损。
- 3期为FDG-PET正常而静息心肌灌注显像存在灌注缺损。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUNDS: High-degree atrioventricular block (AVB) recovery in CS has been shown to be highly variable despite immunosuppressive treatment, with no reliable tool available to predict odds of reversibility. This study sought to evaluate the potential of combined fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) and resting myocardial perfusion imaging (rMPI) to predict reversibility of newly diagnosed high-grade AVB in cardiac sarcoidosis (CS). METHODS: We performed a single-center, retrospective analysis of patients with CS presenting with high-grade AVB who underwent combined FDG-PET/CT and rMPI. The 2016 JCS and the 2014 HRS diagnostic criteria were used for the diagnosis of CS. Patients with a history of coronary artery disease or prior immunosuppressive treatment were excluded. Patients were divided into AVB recovery and non-recovery subgroups. CS disease staging was based on FDG-PET and rMPI findings: (Stage 0) normal FDG-PET and rMPI (Stage 1) positive FDG-PET and normal rMPI (Stage 2) positive FDG-PET with perfusion deficits on rMPI (Stage 3) normal FDG-PET with perfusion deficits on rMPI. RESULTS: Twenty-seven patients, including 13 demonstrating AVB recovery, were identified. Eleven out of fourteen (78.6%) patients presenting with stage 1 CS demonstrated AVB recovery. Stage 1 CS was significantly more present in the recovery group compared to the non-recovery group (84.6% vs 21.4%, P = .002). Eleven presented with stage 2 CS, with only 2 (18.2%) recovering AV nodal conduction. Stage 2 CS presented more frequently in the non-recovery group (64.3% vs 15.4%, P = .020). CONCLUSIONS: Combined FDG-PET and rMPI employed to stage CS disease presenting with high-degree AVB appears to have good performance for predicting likelihood of recovery.
引用
- Lucinian YA, Martineau P, Poenaru R, et al. FDG-PET/CT and rest myocardial perfusion imaging to predict high-degree atrioventricular block recovery in cardiac sarcoidosis. J Nucl Cardiol. 2023. PMID: 37258950. doi:10.1007/s12350-023-03306-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。